Metrics other than potency reveal systematic variation in responses to cancer drugs - Dataset (ID:20120)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10133-2 | Afatinib | BIBW-2992 | LSM-43226 |  | 57519523 |
| 10108-2 | Geldanamycin | LSM-42789 |  | 644250 | |
| 10107-2 | MG-132 | LSM-1107 |  | 462382 | |
| 10102-3 | Taxol | Paclitaxel | LSM-1102 |  | 441276 |
| 10098-2 | Gefitinib | ZD1839; Iressa | LSM-1098 |  | 123631 |
| 10097-3 | Erlotinib | OSI-774 | LSM-1097 |  | 176870 |
| 10062-3 | GSK1070916 | KIN001-216 | LSM-1062 |  | 46885626 |
| 10035-2 | Sigma A6730 | KIN001-102; AKT inhibitor VIII; Akt1/2 kinase inhibitor | LSM-1035 |  | 10196499 |
| 10026-3 | PD173074 | LSM-1026 |  | 1401 | |
| 10023-3 | Imatinib | Gleevec; Glivec; CGP-57148B; STI-571 | LSM-1023 |  | 5291 |
| 10021-5 | Tozasertib | VX680; MK-0457 | LSM-1021 |  | 5494449 |
| 10013-3 | GSK461364 | GSK461364A | LSM-1013 |  | 15983966 |